IGF2BP3 and breast cancer: Yang et al. suggested that IGF2BP3 and IGF2BP2 could be considered specific genes of triple-negative breast cancer, the molecular subtype with the poorest prognosis, which would aid in more precise diagnosis and treatment for breast cancer patients [92].